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Edited by Hans EklundAbstract Aldehyde dehydrogenase (ALDH) isozymes are criti-
cally important in the metabolism of acetaldehyde, thus prevent-
ing its accumulation after ethanol-exposure. We previously
reported that mitochondrial ALDH2 could be inactivated via
S-nitrosylation in ethanol-exposed rats. This study was aimed
at investigating whether cytosolic ALDH1, with a relatively-
low-Km value (11–18 lM) for acetaldehyde, could be also inhib-
ited in ethanol-exposed rats. Chronic or binge ethanol-exposure
signiﬁcantly decreased ALDH1 activity, which was restored by
addition of dithiothreitol. Immunoblot analysis with the anti-S-
nitroso-Cys antibody showed one immunoreactive band in the
immunoprecipitated ALDH1 only from ethanol-exposed rats,
but not from pair-fed controls, suggesting S-nitrosylation of
ALDH1. Therefore inactivation of ALDH1 via S-nitrosylation
can result in accumulation of acetaldehyde upon ethanol-expo-
sure.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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metabolism1. Introduction
Various aldehydes including acetaldehyde and 4-hydroxy-
nonenal are metabolized to corresponding carboxylic acids
by aldehyde dehydrogenase (ALDH)1 isozymes [1–3]. Since
many aldehydes are highly reactive and potentially toxic,
ALDH isozymes are important in cellular detoxiﬁcation
[2,3]. The ALDH superfamily members represent NAD(P)+-
dependent enzymes with broad substrate speciﬁcities and dif-
ferent subcellular locations: class 1 (cytosolic, ALDH1), class
2 (mitochondrial, ALDH2), class 3 (tumor-associated,
ALDH3), succinate semialdehyde dehydrogenase (ALDH5),
etc. [2,3]. In addition, it is known that a genetic polymorphism
in the human ALDH2 gene plays a key role in alcohol-associ-
ated tissue injury and carcinogenesis [4–7].Abbreviations: ALDH1, cytosolic aldehyde dehydrogenase; ALDH2,
mitochondrial aldehyde dehydrogenase; DTT, dithiothreitol; S-NO-
Cys, S-nitroso-cysteine; biotin-NM, biotin-N-maleimide; HRP, horse-
radish peroxidase; ROS/RNS, reactive oxygen/nitrogen species;
FTHFDH, 10-formyltetrahydrofolate dehydrogenase
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doi:10.1016/j.febslet.2007.07.037Mammalian liver class 1 and class 2 ALDH enzymes were
puriﬁed in the 1970s, and have been used extensively as models
for studying their kinetic and structural characterizations.
Both ALDH1 and ALDH2 are tetrameric enzymes with indi-
vidual subunits composed of 500–501 amino acids. They share
68% sequence identity to each other [7,8] and have very similar
three-dimensional structures [9–11]. Mitochondrial ALDH2 in
humans is the major acetaldehyde-oxidizing enzyme with a
very low Km value (61.0 lM range) for acetaldehyde [12–14].
In contrast, both ALDH1 and ALDH2 in rodents are involved
in the metabolism of acetaldehyde at physiological concentra-
tions because rodent ALDH1 isozymes exhibit relatively-low
Km values (11–18 lM range) for acetaldehyde [14]. Isse et al
[15] reported that acetaldehyde concentrations in blood and
many tissues upon ethanol-exposure were markedly elevated
in aldh2/ knockout mice compared to those concentrations
in aldh2+/+ wild type mice. Our previous results with the trans-
genic mice containing the inactive human ALDH2-2 variant
also showed that acute ethanol-exposure signiﬁcantly in-
creased the hepatic acetaldehyde levels without changing the
ethanol levels [16]. Furthermore, we recently identiﬁed cyto-
solic ALDH1 among the oxidatively-modiﬁed proteins in eth-
anol-fed mouse livers [17]. All these results strongly suggest
that ALDH1 could be inhibited through oxidative/nitrosative
modiﬁcations in ethanol-exposed rat livers. Consistent with
this view, Cys residues of mitochondrial ALDH2 was S-nitro-
sylated in nitric oxide-exposed hepatoma cells [18] and etha-
nol-exposed rats [19], leading to inactivation of ALDH2.
However, it is still unknown whether ALDH1 activity can be
altered by ethanol-exposure and whether the suppressed
ALDH1 activity can be restored by reducing agents such as
dithiothreitol (DTT). Based on this information, we hypothe-
sized that ALDH1 can be inactivated by S-nitrosylation of
Cys residue(s) upon ethanol-exposure. The aims of this study
were to test this hypothesis and to examine whether DTT
can reverse the suppressed ALDH1 activity in ethanol-exposed
rats.2. Materials and methods
2.1. Chemicals and other materials
DTT, anti-S-nitroso-cysteine (S-NO-Cys) antibody, biotin-N-malei-
mide (biotin-NM), propionaldehyde, and pyrazole were obtained from
Sigma Chemical (St. Louis, MO, USA) in highest purity. The speciﬁc
goat anti-ALDH1 antibody, (catalog number: sc-22588) which does
not recognize mitochondrial ALDH2, and secondary antibodies conju-
gated with horse-radish peroxidase (HRP) were purchased from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).European Biochemical Societies.
Fig. 1. Presence of ALDH1 protein in the oxidized cytosolic proteins
after ethanol-exposure. Oxidized cytosolic proteins from dextrose-
treated controls () or ethanol-exposed (+) rat livers were labeled with
biotin-NM. Biotin-NM-labeled proteins (20 lg/well) were then sepa-
rated on 12% SDS–PAGE, transferred to PVDF-Immobilon mem-
branes, and stained with Coomassie blue (A) or subjected to
immunoblot analysis using streptavidin–HRP antibodies (B). Presence
of ALDH1 protein in oxidized cytosolic proteins was conﬁrmed by
immunoblot analysis. Biotin-NM-labeled cytosolic proteins before (C)
or after (D) puriﬁcation with streptavidin–agarose were analyzed by
1D SDS–PAGE, and then subjected to immunoblot analysis (IB) using
the speciﬁc anti-ALDH1 antibody. This ﬁgure represents a typical
result from at least two diﬀerent experiments.
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Young male Sprague–Dawley rats (n P 10 from Taconic Farms,
Rockville, MD, USA) were maintained in accordance with the NIH
guidelines and acutely treated with ethanol for four consecutive days
(binge treatment), as recently described [20]. Control rats were treated
in the same manner except for treatment with isocaloric dextrose-con-
taining diet (dextrose control). Young adult Wistar rats (n = 6 per
group from Charles River, Raleigh, NC, USA) were individually
housed and fed a Lieber-DeCarli alcohol liquid diet (with 35% daily
calories derived from ethanol) or an isocaloric dextrose control diet
for 4 weeks, as described [21].
2.3. Labeling of oxidized cytosolic proteins with biotin-NM
Livers, freshly isolated from rats in diﬀerent treatment groups, were
pooled, rinsed with cold phosphate-buﬀered saline to remove blood,
and homogenized with three volumes of STE buﬀer (250 mM sucrose,
50 mM Tris–Cl, pH 7.5, and 1 mM EDTA with protease inhibitor
cocktails). Cytosolic and mitochondrial fractions were prepared by dif-
ferential centrifugation, as described [17–19]. Concentration of the
cytosolic proteins was determined using the BioRad protein assay
kit, as described [19,22]. Labeling of oxidized proteins with biotin-
NM was performed using a previously detailed method [19].
2.4. Measurement of ALDH1 activities
The activity of cytosolic ALDH1 was measured by increased pro-
duction of NADH at 340 nm by following the method of Tank et al.
[23]. The reaction mixture contained: 60 mM Na-pyrophosphate buﬀer
(pH 8.5), 2 mM NAD+, 5 mM pyrazole, 1 mM EDTA and cytosolic
proteins (0.5 mg/assay). After the reaction mixture was kept for
2 min at room temperature, the enzyme reaction was initiated by add-
ing the substrate (15 or 150 lM propionaldehyde). The absorbance
change was monitored for 3 min to calculate the rate of NADH pro-
duction. Speciﬁc activity of ALDH1 was calculated by using the molar
extinction coeﬃcient of reduced NAD(P) of 6.22 · 106 cm2 at 340 nm
(Merck Index), where 1 U represents a reduction of 1 lmole NAD+/
min/mg protein at room temperature.
2.5. Immunoprecipitation of ALDH1 proteins and immunoblot analysis
Cytosolic proteins (2 mg/sample) were incubated with 5 lg of the
speciﬁc antibody to ALDH1 for 2 h with constant agitation followed
by addition of protein A/G-agarose for an additional 1 h to facilitate
immunoprecipitation. Proteins bound to protein A/G-agarose beads
were washed three times with 1· phosphate-buﬀered saline and 1%
CHAPS to remove non-speciﬁcally bound proteins. After the centrifu-
gation, the proteins bound to the antibody and agarose beads were dis-
solved in 1-D Laemmli buﬀer for immunoblot analysis. The unpuriﬁed
cytosolic proteins and immunoprecipitated ALDH1 proteins were re-
solved on SDS–polyacrylamide gels and subjected to immunoblot
analysis with the speciﬁc anti-ALDH1 antibody or anti-S-NO-Cys
antibody with enhanced chemiluminescence detection.
2.6. Data processing and statistical analysis
The data represent the results from at least three separate experi-
ments, unless stated otherwise. Statistical analyses were performed
using the Student’s t-test and P < 0.05 was considered statistically sig-
niﬁcant. Other materials and methods not described here were per-
formed as previously described [17–19].3. Results
3.1. Increased oxidative modiﬁcation of ALDH1 after ethanol-
exposure
Chronic or binge ethanol treatment caused increased levels
and activities of CYP2E1 and iNOS, surrogate marker pro-
teins of oxidative/nitrosative stress, indicating increased oxida-
tive/nitrosative stress in ethanol-exposed tissues [17,19]. To
directly demonstrate the increased levels of oxidized proteins
after ethanol-exposure, cytosolic proteins from the respective
treatment groups were labeled with biotin-NM and subjected
to analysis. Fig. 1A shows a typical pattern of biotin-NM-la-beled proteins stained with Coomassie blue, verifying that sim-
ilar amounts of oxidized protein were analyzed in our study.
Only a small number of biotin-NM-labeled oxidized proteins
were recognized with streptavidin–HRP in the dextrose-treated
control samples (Fig. 1B, lanes 1 and 3). However, the inten-
sity and the number of oxidized proteins detected by streptavi-
din–HRP were greatly increased in chronic and binge ethanol-
treated rat livers, respectively (Fig. 1B, lanes 2 and 4). To fur-
ther demonstrate oxidative modiﬁcation of ALDH1 protein,
biotin-NM labeled cytosolic proteins were analyzed before
and after puriﬁcation with streptavidin–agarose. Immunoblot
analysis using the speciﬁc anti-ALDH1 antibody revealed that
similar amounts of ALDH1 protein were detected in all treat-
ment groups before the puriﬁcation (Fig. 1C). After the strep-
tavidin-mediated puriﬁcation, a single band was recognized
only in ethanol-exposed groups but not in dextrose-treated
Fig. 2. Reversible inactivation of ALDH1 in ethanol-exposed rat
livers. (A) Hepatic ALDH1 activities in pair-fed controls () or
chronically ethanol-fed rats (+) were determined by using 15 or
150 lM propionaldehyde, as indicated. (B) ALDH1 activities in
diﬀerent groups were measured with 15 lM propionaldehyde before
and after incubation with 12 mM DTT. Each point represents the
average ± S.D. of three determinations. *P < 0.005, signiﬁcantly
diﬀerent from the pair-fed controls; **P < 0.001, signiﬁcantly diﬀerent
from the ethanol-fed rats; ***P < 0.005, signiﬁcantly diﬀerent from the
dextrose-treated controls; ****P < 0.005, signiﬁcantly diﬀerent from the
binge ethanol-exposed rats.
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port that ALDH1 was oxidatively-modiﬁed after both chronic
and binge ethanol treatments.
3.2. Reversible inactivation of hepatic ALDH1 in ethanol-
exposed rats
Keung and colleagues [14] reported that rat ALDH1 exhibits
a relatively-low Km value (15 ± 3 lM) for acetaldehyde. Based
on this report, hepatic ALDH1 activity in diﬀerent groups was
determined by using 15 or 150 lM propionaldehyde as a sub-
strate. As shown in Fig. 2A, ALDH1 activity using 15 lM pro-
pionaldehyde was signiﬁcantly inhibited (by 61%) in
chronically ethanol-fed rats compared to that of pair-fed rats.
In contrast, ALDH1 activity in ethanol-fed rats was not inhib-
ited when the activity was determined using 150 lM propion-
aldehyde. These data suggest that only ALDH1 with a
relatively-low-Km for acetaldehyde is likely to be inhibited by
oxidative modiﬁcations. Other cytosolic ALDH isozymes with
high-Km values for acetaldehyde may not be inactivated. He-
patic ALDH1 activities were 1.54 ± 0.24 and 2.14 ± 0.25 U in
chronic and binge ethanol-exposed rats, respectively. These
values represent approximately 61% and 42% reduction,
respectively, of the ALDH1 activity in chronic and binge eth-
anol-treated rats, compared with those of the corresponding
dextrose-treated controls (Fig. 2B). Furthermore, the sup-
pressed ALDH1 activities were completely recovered by the
addition of DTT in both chronic and binge ethanol-treated
groups.
To further elucidate the mechanism for ethanol-mediated
ALDH1 inhibition, the hepatic ALDH1 proteins in the pair-
fed controls or ethanol-fed rats were immunoprecipitated with
the anti-ALDH1 antibody before or after incubation with
DTT. Immunoblot analysis with the anti-ALDH1 antibody
veriﬁed that similar amounts of ALDH1 protein (55 kDa) were
immunoprecipitated from diﬀerent treatment groups (Fig. 3A,
left panel). Immunoblot analysis with the anti-S-NO-Cys anti-
body showed that one immunoreactive band (55 kDa) was rec-
ognized in the ethanol-fed rats (right panel, lane 2) but not in
the pair-fed controls (lane 1). However, the immunoreactive S-
NO-Cys band disappeared (lane 3) when DTT was added prior
to immunoprecipitation of ALDH1 in the ethanol-fed group.Fig. 3. Reversible S-nitrosylation of ALDH1. Liver cytosolic proteins (2 mg/
immunoprecipitate (IP) ALDH1 with the speciﬁc anti-ALDH1 antibody
ALDH1 proteins were divided equally and subjected to immunoblot analys
antibody (right panel). This ﬁgure represents a typical result from two diﬀerThese results of S-nitrosylated ALDH1 protein correlated with
complete recovery of ALDH1 activity in the presence of DTT
(Fig. 2B). These data strongly suggest that inhibition ofanalysis) from pair-fed control () or ethanol-fed rats (+) were used to
before and after incubation with 12 mM DTT. Immunoprecipitated
is using the anti-ALDH1 antibody (left panel) or the anti-S-NO-Cys
ent experiments.
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ible and that critical Cys residues including the active site
Cys of ALDH1 could be S-nitrosylated or subjected to other
oxidative modiﬁcations following exposure to ethanol.4. Discussion
It is well established that heavy ethanol consumption for ex-
tended periods of time can damage various cells and organs,
mainly through increased oxidative/nitrosative stress, mito-
chondrial dysfunction, production of inﬂammatory cytokines,
activation of the cell-death signaling pathways, and decreased
levels of anti-oxidant molecules [24–27]. In fact, ethanol-expo-
sure can activate CYP2E1, NADPH oxidase, and iNOS while
it suppresses the trans-sulfuration and glutathione pathways
[27] as well as the mitochondrial electron transport chain,
resulting in increased production of reactive oxygen/nitrogen
species (ROS/RNS). These elevated ROS/RNS can interact
with DNA, proteins, and lipids, negatively aﬀecting their cellu-
lar functions. In addition, recent results from this laboratory
indicated that peroxiredoxin, involved in removal of peroxides
[17], and mitochondrial ALDH2, a major enzyme in the
metabolism of toxic acetaldehyde and lipid peroxides such as
4-hydroxynoenal, were inhibited after chronic and binge etha-
nol treatments [19]. Recent data with aldh2 knockout mice [15]
and transgenic mice containing the inactive human ALDH2-2
variant [16] showed that acetaldehyde was signiﬁcantly
elevated after acute ethanol exposure. Moreover, our previous
results [17] clearly showed that ALDH1 was oxidatively-
modiﬁed in ethanol-fed mouse livers. These data suggest that
cytosolic ALDH1 with low-Km values for acetaldehyde must
be inactivated during and after ethanol treatment. Potential
inhibition of ALDH1 and its implication on acetaldehyde
accumulation following ethanol-exposure have not been char-
acterized systematically, although many reports showed inhibi-
tion of mitochondrial ALDH2 by toxic chemicals [19,28,29]
and in pathological conditions [4–6,30]. Therefore, this study
was aimed at investigating whether hepatic ALDH1 activityTable 1
Comparison of the peptide sequences at the active site cysteine of rat ALDH
*Active site cysteine.
Dark gray boxes show 100% identical amino acids and light gray boxes s
drogenase; FTHFDH, 10-formyltetrahydrofolate dehydrogenase (aldehyde dcould be inhibited in ethanol-exposed rats and whether oxida-
tive modiﬁcation of its Cys residue(s) could play a role in the
ALDH1 inhibition.
It is known that Cys residues in many proteins can be mod-
iﬁed by any of the following modiﬁcations: oxidation to disul-
ﬁdes [31], sulfenic acid [32], sulﬁnic acid and sulfonic acid [33],
glutathione-dependent S-glutathionylation [34], NO-depen-
dent S-nitrosylation [35], NO-independent ADP-ribosylation
[36], etc. Using site-directed mutagenesis followed by biochem-
ical characterizations, Weiner and coworkers [37] demon-
strated that Cys302 of ALDH2 is the active site Cys, which is
highly conserved among the ALDH2 superfamily members.
To further identify the active site of ALDH1, we aligned the
peptide sequences around the putative active site Cys of major
ALDH isozymes and compared those with Cys302 of ALDH2
[37]. As listed in Table 1, all of these ALDH isozymes includ-
ing ALDH1 have similar peptide sequences around the active
site Cys, which is 100% identical among all the ALDH iso-
zymes we compared. Based on this structural comparison,
Cys303 is considered the active site of ALDH1 and that this
Cys was likely to be oxidatively modiﬁed after ethanol-expo-
sure, resulting in its inactivation. It is conceivable that other
Cys residues and/or other amino acid residues of ALDH1
may be also oxidatively-modiﬁed, contributing to inactivation
of its activity. In fact, our preliminary results show that tyro-
sine residue(s) of cytosolic ALDH1 could be nitrated in etha-
nol-treated rats. Furthermore, Cys303 and other Cys residues
of ALDH1 can be modiﬁed after exposure to toxic chemicals
or under pathophysiological conditions, similar to those pres-
ent to modify ALDH2 [19,28,29].
Our current results show that ALDH1 is inhibited by etha-
nol-mediated S-nitrosylation based on the following facts: (1)
identiﬁcation of ALDH1 in oxidized cytosolic proteins after
ethanol-exposure; (2) inhibition of ALDH1 activity; (3) S-nit-
rosylation of Cys in immunoprecipitated ALDH1 recognized
with the anti-S-NO-Cys antibody; (4) restoration of the sup-
pressed ALDH1 activity by DTT; (5) disappearance of the
S-nitrosylated ALDH1 band in the presence of DTT. To our
knowledge, our results represent the ﬁrst report to show theisozymes
how highly conserved amino acids. RALDH2, retinal aldehyde dehy-
ehydrogenase 1 family member L1).
K.-H. Moon et al. / FEBS Letters 581 (2007) 3967–3972 3971inactivation of ALDH1 in rat livers via ethanol-mediated S-
nitrosylation. Other ALDH isozymes, with high-Km values
for acetaldehyde but low-Km values for their speciﬁc sub-
strates, do not seem to be inhibited when 150 lM propionalde-
hyde was used in the current study. Since other ALDH
isozymes such as ALDH3, ALDH5, ALDH6, ALDH9,
RALDH2, and 10-formyltetrahydrofolate dehydrogenase
(FTHFDH) also have similar structures at their active sites
(Table 1), the activities of these ALDH isozymes are likely
to be inhibited, if measured with their speciﬁc substrates, by
similar mechanisms upon exposure to ethanol or toxic chemi-
cals that produce reactive intermediates and/or ROS/RNS. For
instance, FTHFDH, involved in the metabolism of tetrahydro-
folate, is another member of NADP+-dependent ALDH fam-
ily. This enzyme contains an active site Cys (Cys707) with a
C-terminal domain (amino acids 420–902) similar to that of
NAD+-dependent ALDH2 [38,39]. The activity of FTHFDH
was signiﬁcantly inhibited in the ethanol-fed rat liver, although
the inhibitory mechanism was not characterized [40]. In addi-
tion, the activity of FTHFDH was inhibited after acute treat-
ment with a hepatotoxin acetaminophen [41]. The structural
comparison (Table 1) and biochemical results [40,41] can sup-
port our view about potential inhibition of other ALDH iso-
zymes via oxidative modiﬁcations, especially when their
activities are determined with their speciﬁc substrates. Further-
more, since ALDH isozymes are important in the metabolism
of potentially toxic aldehydes, inactivation of ALDH isozymes
by various toxic chemicals is likely to cause marked accumula-
tion of toxic aldehydes, leading to increased susceptibility to-
wards irreversible damage. Our current results not only
explain the accumulation of acetaldehyde in ethanol-treated
aldh2 knockout mice but also indicate that aldh2 knockout
mice might still be used as a model to study the role of elevated
acetaldehyde in ethanol preference [42], acetaldehyde accumu-
lation [15], and acetaldehyde-mediated DNA damage [43] or
tissue damage [44] after long-term exposure to ethanol or acet-
aldehyde.
In conclusion, we have studied the mechanism of ALDH1
inhibition after ethanol-exposure. Our results show that hepa-
tic ALDH1 can be S-nitrosylated in ethanol-exposed rats,
leading to inhibition of its activity. Our current results may
help explain the underlying mechanisms of ALDH1 inhibition
and accumulation of acetaldehyde or lipid peroxides following
exposure to ethanol or other toxic agents.
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